Cognyte Software Ltd. (NASDAQ:CGNT) Shares Bought by American Capital Management Inc.

American Capital Management Inc. increased its holdings in shares of Cognyte Software Ltd. (NASDAQ:CGNT - Free Report) by 8.5% in the third quarter, according to its most recent filing with the SEC. The fund owned 6,402,813 shares of the medical device company's stock after acquiring an additional 502,781 shares during the period. Cognyte Software comprises 1.4% of American Capital Management Inc.'s portfolio, making the stock its 29th biggest position. American Capital Management Inc. owned about 8.91% of Cognyte Software worth $43,475,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. Signaturefd LLC lifted its position in shares of Cognyte Software by 91.4% during the second quarter. Signaturefd LLC now owns 3,311 shares of the medical device company's stock worth $25,000 after purchasing an additional 1,581 shares during the last quarter. Silverberg Bernstein Capital Management LLC lifted its holdings in Cognyte Software by 2.0% during the 3rd quarter. Silverberg Bernstein Capital Management LLC now owns 100,300 shares of the medical device company's stock valued at $681,000 after buying an additional 2,000 shares in the last quarter. Legacy Advisors LLC boosted its position in Cognyte Software by 1.4% in the 2nd quarter. Legacy Advisors LLC now owns 143,790 shares of the medical device company's stock valued at $1,099,000 after buying an additional 2,041 shares during the period. nVerses Capital LLC bought a new position in Cognyte Software in the 2nd quarter worth about $28,000. Finally, State of New Jersey Common Pension Fund D increased its position in shares of Cognyte Software by 34.4% during the third quarter. State of New Jersey Common Pension Fund D now owns 23,186 shares of the medical device company's stock worth $157,000 after acquiring an additional 5,940 shares during the period. Hedge funds and other institutional investors own 72.92% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Needham & Company LLC reiterated a "hold" rating on shares of Cognyte Software in a report on Tuesday, September 10th. StockNews.com lowered Cognyte Software from a "strong-buy" rating to a "buy" rating in a research report on Friday, November 22nd.

Cognyte Software Price Performance

Shares of NASDAQ:CGNT traded up $0.16 during trading hours on Friday, hitting $8.12. The company's stock had a trading volume of 64,742 shares, compared to its average volume of 251,082. The firm's fifty day moving average price is $6.97 and its 200 day moving average price is $7.30. Cognyte Software Ltd. has a 52 week low of $5.00 and a 52 week high of $8.70. The company has a market capitalization of $583.75 million, a price-to-earnings ratio of -115.98 and a beta of 1.72.

Cognyte Software (NASDAQ:CGNT - Get Free Report) last issued its quarterly earnings data on Tuesday, September 10th. The medical device company reported $0.05 EPS for the quarter, topping analysts' consensus estimates of ($0.02) by $0.07. The company had revenue of $84.40 million during the quarter, compared to the consensus estimate of $83.69 million. Cognyte Software had a negative net margin of 1.35% and a negative return on equity of 2.56%. Cognyte Software's revenue for the quarter was up 9.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted ($0.11) earnings per share. On average, equities research analysts predict that Cognyte Software Ltd. will post -0.28 earnings per share for the current fiscal year.

Cognyte Software announced that its board has approved a share repurchase program on Tuesday, November 12th that authorizes the company to repurchase $20.00 million in shares. This repurchase authorization authorizes the medical device company to repurchase up to 3.7% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company's leadership believes its shares are undervalued.

Insider Activity at Cognyte Software

In other news, major shareholder Topline Capital Partners, Lp purchased 553,591 shares of the business's stock in a transaction on Wednesday, September 11th. The shares were acquired at an average cost of $6.31 per share, with a total value of $3,493,159.21. Following the completion of the acquisition, the insider now owns 8,604,144 shares of the company's stock, valued at $54,292,148.64. This trade represents a 6.88 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Topline Capital Management, Ll acquired 416,040 shares of the firm's stock in a transaction dated Thursday, September 12th. The shares were acquired at an average price of $6.30 per share, with a total value of $2,621,052.00. Following the acquisition, the insider now owns 9,020,184 shares in the company, valued at approximately $56,827,159.20. The trade was a 4.84 % increase in their position. The disclosure for this purchase can be found here. 62.70% of the stock is owned by corporate insiders.

About Cognyte Software

Cognyte Software Ltd. provides an investigative analytics software to governments and enterprises worldwide. Its Actionable Intelligence for a Safer World, an open software designed to help governments and enterprises accelerate and enhance the effectiveness of investigations. The company offers network intelligence analytics, threat intelligence analytics, decision intelligence analytics, and operational intelligence analytics solutions.